1673-5269
2012 Issue 23
Safety in the neoadjuvant chemotherapy combined with breast-conserving surgery treatment of T2 breast cancer
ZHANG Zhen1;LIANG Hong2 1.Department of General Surgery;Mengyin People’s Hospital;Mengyin 276200;P.R.China 2.Department of Thyroid and Breast Surgery;Linyi People’s Hospital;Linyi 276000;P.R.China
ZHANG Zhen1;LIANG Hong2 1.Department of General Surgery;Mengyin People’s Hospital;Mengyin 276200;P.R.China 2.Department of Thyroid and Breast Surgery;Linyi People’s Hospital;Linyi 276000;P.R.China
..............page:1813-1815
Effect of Docetaxel on the proliferation of triple negative breast cancer cell line and its mechanism
ZHA Quan-bin1;TANG Jin-hai2;JI Ming-hua2;WU Jian-zhong2;QIAO En-qi3;HE Yue-jun1 1.Xuzhou Medical College;Xuzhou 221004;P.R.China 2.Jiangsu Cancer Hospital;Nanjing 210009;P.R.China 3.Department of Oncology;Nanjing Medical University;Nanjing 210029;P.R.China
ZHA Quan-bin1;TANG Jin-hai2;JI Ming-hua2;WU Jian-zhong2;QIAO En-qi3;HE Yue-jun1 1.Xuzhou Medical College;Xuzhou 221004;P.R.China 2.Jiangsu Cancer Hospital;Nanjing 210009;P.R.China 3.Department of Oncology;Nanjing Medical University;Nanjing 210029;P.R.China
..............page:1761-1766
Research advance on RASSF1A gene and breast cancer
WANG Zeng-yan;LI Jian-guo Department of Ordinary Surgical;Zhangzhou Hospital of Fujian Medical University;Zhangzhou 363000;P.R.China
WANG Zeng-yan;LI Jian-guo Department of Ordinary Surgical;Zhangzhou Hospital of Fujian Medical University;Zhangzhou 363000;P.R.China
..............page:1836-1840
..............page:1841-1842
yuan fa xing ru xian shen jing nei fen mi ai yi li bao gao
li wen feng gao li liang jun
li wen feng gao li liang jun
..............page:1827-1828
Correlation of intra-fraction displacement of the mediastinal metastatic lymph nodes with displacement of primary tumor and rates of volume change of lung and heart based on 4D-CT
WANG Su-zhen;LI Jian-bin;ZHANG Ying-jie;LI Feng-xiang;SHAO Qian;FAN Ting-yong;XU Min;QI Huan-peng Department of Radiation Oncology;Shandong Cancer Hospital;Jinan 250117;P.R.China
WANG Su-zhen;LI Jian-bin;ZHANG Ying-jie;LI Feng-xiang;SHAO Qian;FAN Ting-yong;XU Min;QI Huan-peng Department of Radiation Oncology;Shandong Cancer Hospital;Jinan 250117;P.R.China
..............page:1818-1822
..............page:1843
Inhibitory effect of 15-hydroxyprostaglandin dehydrogenase gene on the growth of gastric cancer cell MFC
LI Li-hua;WANG Xiao-jie;HU Jing;YANG Li-bo;SHOU Tao Department of Medicine Oncology;First People’s Hospital of Yunnan Province;Affiliated Hospital of Kunming Science and Engineering University;Kunming 650032;P.R.China
LI Li-hua;WANG Xiao-jie;HU Jing;YANG Li-bo;SHOU Tao Department of Medicine Oncology;First People’s Hospital of Yunnan Province;Affiliated Hospital of Kunming Science and Engineering University;Kunming 650032;P.R.China
..............page:1785-1789
Construction of human small cell lung cancer animal model of macaca fascicularis
ZHOU Feng-li;WU Shao-zhu;CHEN Jian-ning;BI Xiao-gang;ZHANG Tian-tuo Department of Respiration;Third Affiliated Hospital;Sun Yat-sen University;Guangzhou 510630;P.R.China
ZHOU Feng-li;WU Shao-zhu;CHEN Jian-ning;BI Xiao-gang;ZHANG Tian-tuo Department of Respiration;Third Affiliated Hospital;Sun Yat-sen University;Guangzhou 510630;P.R.China
..............page:1776-1779,1840
Sensitivity research on gastric cancer tau protein expression and the use of paclitaxel
WANG Qiong1;WANG Nan-yao1;QIAN Jian-zhong1;SHEN Dong1;YUAN Ming1;LI Su-yi2;MAO Wei-dong1 1.Jiangyin Hospital;Medical College of Southeast University;Jiangyin 214400;P.R.China 2.Department of Oncology;Nanjing Zhongda Hospital of Southeast University Medical College;Nanjing 210006;P.R.China
WANG Qiong1;WANG Nan-yao1;QIAN Jian-zhong1;SHEN Dong1;YUAN Ming1;LI Su-yi2;MAO Wei-dong1 1.Jiangyin Hospital;Medical College of Southeast University;Jiangyin 214400;P.R.China 2.Department of Oncology;Nanjing Zhongda Hospital of Southeast University Medical College;Nanjing 210006;P.R.China
..............page:1800-1804
nan xing shuang ce yuan fa xing ru xian ai yi li bao gao bing wen xian fu xi
hu chong zhu yang ying ma ning fang zhi yi
hu chong zhu yang ying ma ning fang zhi yi
..............page:1829-1830
Clinical significance research of BRCA1 and Ki-67 expression in Xinjiang Uygur and Han nationality triple-negative breast cancer
SONG Mu1;DU Lu2;QI Xin3;ZHANG Ming-shuai3;DILIXIATI·Jin-sihan3;ZHU Li-ping3 1.Department of Oncological Surgery;Second Affiliated Hospital;Xinjiang Medical University;Urumqi 830049;P.R.China 2.Graduate College;Xinjiang Medical University;Urumqi 830063;P.R.China 3.Department of Breast Surgery;Subsidiary Tumor Hospital;Xinjiang Medical University;Urumqi 830011;P.R.China
SONG Mu1;DU Lu2;QI Xin3;ZHANG Ming-shuai3;DILIXIATI·Jin-sihan3;ZHU Li-ping3 1.Department of Oncological Surgery;Second Affiliated Hospital;Xinjiang Medical University;Urumqi 830049;P.R.China 2.Graduate College;Xinjiang Medical University;Urumqi 830063;P.R.China 3.Department of Breast Surgery;Subsidiary Tumor Hospital;Xinjiang Medical University;Urumqi 830011;P.R.China
..............page:1767-1770
Comparison of vinorelbine plus lobaplatin or cisplatin in the treatment of advanced breast cancer
LIU Ling-li;LIU Jian-lun;YANG Hua-wei;JIANG Yi;WEI Wei;TANG Wei Department of Breast Surgery;Cancer Hospital;Guangxi Medical University;Nanning 530021;P.R.China
LIU Ling-li;LIU Jian-lun;YANG Hua-wei;JIANG Yi;WEI Wei;TANG Wei Department of Breast Surgery;Cancer Hospital;Guangxi Medical University;Nanning 530021;P.R.China
..............page:1810-1812
..............page:1844
Expression of hsa-miR-143/145 cluster in human ESCC cell line and bioinformatics analysis
JIANG Sen1;2;YANG Xiao-di3;WANG Xiu-fang1;2;BAO Zi-chao2;FU Hai-long1;2;DU Yun-xiang2;ZHAO Ya-ping2 1.Department of Graduate;Bengbu Medical College;Bengbu 233000;P.R.China 2.No.82 Hospital of the PLA;Huaian 223001;P.R.China 3.Department of Gastroenterology;Ruijin Hospital;Medical School of Shanghai Jiaotong University;Shanghai 200025;P.R.China
JIANG Sen1;2;YANG Xiao-di3;WANG Xiu-fang1;2;BAO Zi-chao2;FU Hai-long1;2;DU Yun-xiang2;ZHAO Ya-ping2 1.Department of Graduate;Bengbu Medical College;Bengbu 233000;P.R.China 2.No.82 Hospital of the PLA;Huaian 223001;P.R.China 3.Department of Gastroenterology;Ruijin Hospital;Medical School of Shanghai Jiaotong University;Shanghai 200025;P.R.China
..............page:1790-1794
..............page:1844
Bioinformatics-based analysis of signaling pathways for differently expressed microRNAs between different ER status breast cancers
JIANG Mao-zhu;ZENG Rong;MAI Zhong-lun;WU Gang;ZHENG Yan-fang;ZHANG Ji-ren Oncology Center;Zhujiang Hospital;Southern Medical University;Guangzhou 510282;P.R.China
JIANG Mao-zhu;ZENG Rong;MAI Zhong-lun;WU Gang;ZHENG Yan-fang;ZHANG Ji-ren Oncology Center;Zhujiang Hospital;Southern Medical University;Guangzhou 510282;P.R.China
..............page:1795-1799
Application of X-ray guidewire location to pure clustered calcification of breasts
LI Yun1;LI Wen-wu1;HU Da-wei1;ZHAO Shan-sheng1;LIU Yan-song1;LI Tong-yi2;ZHENG Gang1;ZUO Wen-shu1;YU Zhi-yong1 1.Shandong Cancer Hospital;Jinan 250117;P.R.China 2.Department of General Surgery;Zibo Linzi District Qidu Hospital;Zibo 255400;P.R.China
LI Yun1;LI Wen-wu1;HU Da-wei1;ZHAO Shan-sheng1;LIU Yan-song1;LI Tong-yi2;ZHENG Gang1;ZUO Wen-shu1;YU Zhi-yong1 1.Shandong Cancer Hospital;Jinan 250117;P.R.China 2.Department of General Surgery;Zibo Linzi District Qidu Hospital;Zibo 255400;P.R.China
..............page:1816-1817
Intraperitoneal perfusion of pemetrexed on malignant ascites of H22 ascites-bearing mice model
LI Yong-qiang;PAN Qi-jin;HU Xiao-hua;LIU Zhi-hui;LIAO Xiao-li;LIN Yan Department of Chemotherapy Ⅰ;Affiliated Tumor Hospital of Guangxi Medical University;Nanning 530021;P.R.China
LI Yong-qiang;PAN Qi-jin;HU Xiao-hua;LIU Zhi-hui;LIAO Xiao-li;LIN Yan Department of Chemotherapy Ⅰ;Affiliated Tumor Hospital of Guangxi Medical University;Nanning 530021;P.R.China
..............page:1780-1784
Review on RUNX3 gene and esophageal cancer
WANG Shuai;WANG Zhou Department of Thoracic Surgery;Provincial Hospital Affiliated to Shandong University;Jinan 250021;P.R.China
WANG Shuai;WANG Zhou Department of Thoracic Surgery;Provincial Hospital Affiliated to Shandong University;Jinan 250021;P.R.China
..............page:1831-1835
..............page:1843
Inhibition effect of brucine percutaneous administration on bone metastasis in breast cancer
XIA Ke-chun1;ZHANG Mei2;LI Ping2 1.Department of Oncology;Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine;Hefei 230061;P.R.China 2.Department of Traditional Chinese Medicine;Anhui Provincial Hospital;Hefei 230001;P.R.China
XIA Ke-chun1;ZHANG Mei2;LI Ping2 1.Department of Oncology;Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine;Hefei 230061;P.R.China 2.Department of Traditional Chinese Medicine;Anhui Provincial Hospital;Hefei 230001;P.R.China
..............page:1771-1775
Comparison of dosimetry between three dimension conformal radiotherapy and intensity modulated radiotherapy plan for local advanced cardiac carcinoma
LI Jia;YU Yong-hua;LU Jie;LIU Xi-jun;ZHANG Yong Department Of Radiation Oncology;Shandong Cancer Hospital;Jinan 250117;P.R.China
LI Jia;YU Yong-hua;LU Jie;LIU Xi-jun;ZHANG Yong Department Of Radiation Oncology;Shandong Cancer Hospital;Jinan 250117;P.R.China
..............page:1823-1826
Predition value of Ki-67 and molecular subtypes of breast cancer to sensibility of neoadjuvant chemotherapy
WANG Yong-nan;WANG Qi;ZHANG An-qin;HAN Xiao-rong;XU Juan;LI Wen-ping Breast Diseases Center;Guangdong Women and Children Hospital;Guangzhou Medical College;Guangzhou 510010;P.R.China
WANG Yong-nan;WANG Qi;ZHANG An-qin;HAN Xiao-rong;XU Juan;LI Wen-ping Breast Diseases Center;Guangdong Women and Children Hospital;Guangzhou Medical College;Guangzhou 510010;P.R.China
..............page:1805-1809